Cargando…
Update on Optimal Management of Acute Myeloid Leukemia
Acute myeloid leukemia (AML) represents a malignant accumulation of immature myeloid cells in the marrow, presenting with impaired hematopoiesis and its attendant complications, including bleeding, infection, and organ infiltration. Chromosomal abnormalities remain the most powerful predictors of AM...
Autores principales: | El Rassi, Fuad, Arellano, Martha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Libertas Academica
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748090/ https://www.ncbi.nlm.nih.gov/pubmed/23997579 http://dx.doi.org/10.4137/CMO.S8528 |
Ejemplares similares
-
Updates on the Management of Acute Myeloid Leukemia
por: Huerga-Domínguez, Sofía, et al.
Publicado: (2022) -
Bosutinib: a SRC–ABL tyrosine kinase inhibitor for treatment of chronic myeloid leukemia
por: Rassi, Fuad El, et al.
Publicado: (2013) -
Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors
por: Kong, Jee Hyun, et al.
Publicado: (2020) -
‘Acute myeloid leukemia: a comprehensive review and 2016 update'
por: De Kouchkovsky, I, et al.
Publicado: (2016) -
Update on the role of gemtuzumab-ozogamicin in the treatment of acute
myeloid leukemia
por: Swaminathan, Mahesh, et al.
Publicado: (2023)